Klumpers, L. E., Roy, C., Ferron, G., Turpault, S., Poitiers, F., Pinquier, J., . . . van Gerven, J. M. A. (2013). Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ(9)-tetrahydrocannabinol-induced central nervous system and heart rate effects in humans. Blackwell Science Inc.
Chicago Style CitationKlumpers, Linda E., et al. Surinabant, a Selective Cannabinoid Receptor Type 1 Antagonist, Inhibits Δ(9)-tetrahydrocannabinol-induced Central Nervous System and Heart Rate Effects in Humans. Blackwell Science Inc, 2013.
Cita MLAKlumpers, Linda E., et al. Surinabant, a Selective Cannabinoid Receptor Type 1 Antagonist, Inhibits Δ(9)-tetrahydrocannabinol-induced Central Nervous System and Heart Rate Effects in Humans. Blackwell Science Inc, 2013.